文献速递自身免疫性与大疱性皮肤病

非大疱性类天疱疮:临床表现、诊断、治疗反应与预后

Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis.
PubMed 文献 · J Am Acad Dermatol · 2019-04-19

该回顾性研究纳入69例非大疱性类天疱疮患者,平均诊断延迟29个月,皮损以瘙痒性丘疹/结节(37%)或无原发皮损的瘙痒(22%)为主,组织病理多为非特异性,直接和间接免疫荧光阳性率分别为60%和69%,随访中17%出现水疱,1、2、3年死亡率分别为14%、34%、46%,全因死亡风险增加8.6倍。

要点

  • 非大疱性类天疱疮皮损异质性强,诊断延迟常见(平均29个月)。
  • 直接和间接免疫荧光是诊断关键,组织病理多为非特异性。
  • 随访中17%出现水疱,与间接免疫荧光阳性及BP180免疫印迹阳性相关。

核心结论

  • 非大疱性类天疱疮表现为异质性瘙痒性皮损,导致诊断延迟,直接和间接免疫荧光是诊断关键。
  • 随访期间观察到全因死亡风险增加。

研究设计与样本

  • 回顾性病历 review 研究,纳入69例患者。
  • 类天疱疮诊断需满足以下3条标准中的2条:瘙痒、直接免疫荧光显微镜检查阳性、盐裂皮肤间接免疫荧光显微镜检查阳性。

主要发现

  • 平均诊断延迟29个月。
  • 皮肤检查最常见为瘙痒性丘疹/结节(37%)或无原发皮损的瘙痒(22%)。
  • 组织病理学发现主要为非特异性。
  • 直接和间接免疫荧光显微镜检查阳性率分别为60%和69%。
  • 随访期间17%出现水疱,与间接免疫荧光显微镜检查阳性(P = .014)和BP180免疫印迹阳性(P = .032)相关。

关键数值与推荐

  • 诊断标准:满足瘙痒、直接免疫荧光阳性、盐裂皮肤间接免疫荧光阳性3条中的2条。
  • 直接免疫荧光阳性率60%,间接免疫荧光阳性率69%。
  • 随访中水疱形成率17%,与间接免疫荧光阳性(P = .014)和BP180免疫印迹阳性(P = .032)相关。
  • 1、2、3年死亡率分别为14%、34%、46%,全因死亡风险增加8.6倍。

临床怎么用

  • 对瘙痒性丘疹/结节或无原发皮损的瘙痒患者,应怀疑非大疱性类天疱疮。
  • 诊断应依赖直接和间接免疫荧光显微镜检查,而非组织病理学。
  • 随访中需警惕水疱形成及全因死亡风险增加。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nonbullous pemphigoid is an under-recognized phenotype of the autoimmune bullous disease pemphigoid, characterized by the absence of blisters. Several disease aspects have not been studied previously. OBJECTIVE: To describe the characteristics of nonbullous pemphigoid. METHODS: A retrospective review study of medical records. The diagnosis of pemphigoid was based on meeting 2 of the following 3 criteria: (1) pruritus, (2) positive direct immunofluorescence microscopy, or (3) positive indirect immunofluorescence microscopy on salt-split skin. RESULTS: The review included 69 patients. The mean delay in diagnosis was 29 months. Skin examination most often showed pruritic papules/nodules (37%) or pruritus without primary skin lesions (22%). Histopathologic findings were mainly nonspecific. Results of direct and indirect immunofluorescence microscopy were positive in 60% and 69%, respectively. During follow-up, blisters formed in 17%, which was associated with a positive indirect immunofluorescence microscopy (P = .014) and a positive BP180 immunoblot result (P = .032). The Kaplan-Meier estimates of mortality at 1, 2, and 3 years were 14%, 34%, and 46%, respectively, with an 8.6-fold increased all-cause mortality risk. LIMITATIONS: The retrospective study design. CONCLUSIONS: Nonbullous pemphigoid presented with heterogeneous pruritic skin lesions, resulting in delayed diagnosis. Direct and indirect immunofluorescence microscopy are essential to diagnose nonbullous pemphigoid, in contrast to histopathology, mainly showing nonspecific findings. An increased all-cause mortality risk was observed during follow-up.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Lamberts A, Meijer JM, Pas HH, et al. Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis. J Am Acad Dermatol. 2019. PMID: 31009674. doi:10.1016/j.jaad.2019.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。